British Pharma Giant GSK's Blockbuster Shingles And Respiratory Syncytial Virus Vaccine Q2 Sales Miss Expectations, Cuts Annual Vaccine Revenue Guidance

Vaccine sales at GSK declined slightly, with strong demand for Meningitis vaccines and Arexvy in the U.S. Specialty Medicine sales surged by 20%, driven by growth in HIV, Respiratory/Immunology, and Oncology sectors.